LETTER:Information needed on drug use in psychiatry
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.From Dr S. P. Sashidharan
and Dr P. Bracken
Sir: We should be grateful to Mind, Marjorie Wallace and others for highlighting the issues surrounding the use and abuse of drugs used in psychiatry (Letters, 12 and 13 June). Such drugs have been prescribed widely for nearly four decades now, with the enthusiastic support of the profession and the pharmaceutical industry. However, the limitations and side- effects of their use have not been fully acknowledged.
Mind's publication of the concerns about the serious side-effects and debilitating long-term consequences of psychotropic drugs is timely and requires a reasoned and sympathetic response from the mental health professions, especially psychiatrists. However, there are two other issues relevant to this debate. While there is impressive evidence that medications may have a useful role in alleviating many of the immediate symptoms associated with mental illness, it is unlikely that they are curative, or that their benefits outweigh the risks associated with continuous and long-term use. The increasing use of these drugs as the mainstay of psychiatric treatment is also often associated with a lack of acknowledgement of underlying social and psychological antecedents of most mental illness.
We have serious concerns about the lack of choice that many patients experience in relation to prescription of these drugs and, in particular, the almost routine use of these drugs in controlling behaviour, especially in hospital settings. This is especially true in relation to minority ethnic groups, particularly Afro-Caribbean patients referred to psychiatric services. There is evidence that the major tranquillisers are being used inappropriately, usually in doses much larger than the generally agreed guidelines. This has led to increasing disenchantment with the use of medication in the community at large and, regrettably, the potential benefits from prudent use of this medication are ignored in such a context.
Following the death of Orville Blackwood, a young black man in Broadmoor Hospital, an inquiry recommended a review of the prescription of such drugs, but regrettably this has not resulted in any major changes in the prescribing habits of psychiatrists. It is time that we, as a profession, started listening to the genuine and legitimate concerns of our service users and mental health organisations about the use of psychiatric drugs.
Yours sincerely,
S. P. SASHIDHARAN
Clinical Director,
North Birmingham
Mental Health Trust
P. BRACKEN
Consultant Psychiatrist
Department of Psychiatry
University of Birmingham
16 June
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments